Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash FlowTip Ranks·Mar 19 at 09:11 AM000028+1.11%600056+0.53%
In the "Pharmaceutical Spring Festival Gala" in the United States, Chinese pharmaceutical companies have transformed from "optional consumption" to "essential consumption."Wallstreetcn·Jan 14 at 12:45 AM600056+0.53%
China Meheco: Subsidiary Tianfang Pharmaceutical's Nicardipine Tablets intend to be selected for the 11th batch of national centralized drug procurementZhitong·Oct 28, 2025 at 04:53 AM600056+0.53%
China Meheco's 3 billion ultra-short-term financing bond registration accepted by the Association of DealersZhitong·Oct 10, 2025 at 05:59 AM600056+0.53%
China Meheco signed a strategic cooperation framework agreement with the Faku County GovernmentZhitong·Sep 26, 2025 at 01:11 AM600056+0.53%
Some domestic and foreign investment institutions visited the National Healthcare Security AdministrationZhitong·Sep 23, 2025 at 07:27 PM600056+0.53%
China Meheco's subsidiary has passed the consistency evaluation of the generic drug Lincomycin Hydrochloride InjectionZhitong·Sep 23, 2025 at 03:12 AM600056+0.53%
The pharmaceutical commercial sector experiences a surge, China Meheco hits the daily limit upZhitong·Sep 18, 2025 at 12:15 AM600056+0.53%301017-0.80%
Ministry of Industry and Information Technology: Promote the deep empowerment of artificial intelligence in the entire pharmaceutical industry chain and guide enterprises to compete in an orderly manner in accordance with laws and regulationsZhitong·Sep 11, 2025 at 07:59 PM600056+0.53%
China Meheco: Net profit of 294 million yuan in the first half of 2025, a year-on-year decrease of 16.19%Zhitong·Aug 27, 2025 at 04:49 AM600056+0.53%
China Meheco's subsidiary has obtained CEP certification for clindamycin phosphate raw materialsZhitong·Aug 13, 2025 at 03:14 AM600056+0.53%
China Meheco's subsidiary receives approval notice for the listing application of fumaric acid vorinostat chemical raw materialsZhitong·Aug 13, 2025 at 03:11 AM600056+0.53%
The 8th Changbai Mountain Pharmaceutical and Health Industry Development Forum was held in TonghuaZhitong·Aug 10, 2025 at 06:37 AM01643+3.19%600056+0.53%
China Meheco: Due to work adjustments, Ms. Hu Huidong has applied to resign from her positions as a director, a member of the board's special committee, and general manager of the company, and will no longer hold any position in the companyWallstreetcn·Jul 17, 2025 at 03:58 AM600056+0.53%
China Meheco: The application for the listing of hydrochlorothiazide has been approvedZhitong·Jul 7, 2025 at 03:12 AM600056+0.53%
